免責聲明: 本站彙整 FDA、ClinicalTrials.gov、PubMed、SEC EDGAR 等官方公開資料,僅供一般參考,不構成醫療建議、診斷、治療建議或投資建議。

FDA 510(k)

iovera° 系統

K 號:K243677 · 2024-12-26

決定日期2024-12-26
產品代碼GXH
諮詢委員會NE (請提供完整的英文描述,以便進行翻譯。)
決定相當於

器材摘要

iovera° System is the device name listed in this FDA 510(k) record. The listed applicant is Pacira Biosciences, Inc.. It received FDA 510(k) clearance on 2024-12-26 under 510(k) number K243677. The device is classified under product code GXH. It was reviewed by the NE advisory panel. FDA Decision: Substantially Equivalent.

常見問題

What is the iovera° System?

iovera° System is a medical device that received FDA 510(k) clearance on 2024-12-26. The listed applicant is Pacira Biosciences, Inc.. The 510(k) number is K243677.

When did iovera° System receive FDA 510(k) clearance?

iovera° System received FDA 510(k) clearance on 2024-12-26, under 510(k) number K243677.

Who is the listed applicant for iovera° System?

The FDA 510(k) record lists Pacira Biosciences, Inc. as the applicant. This does not by itself establish the device manufacturer.

What is the FDA product code for iovera° System?

The FDA product code for iovera° System is GXH.

相關臨床試驗

相關紀錄係使用名稱、產品代碼或其他後設資料自動配對。配對結果並不構成已驗證的臨床、科學、企業或監管關係,請查閱連結的官方來源。

其他以 Pacira Biosciences, Inc. 為申請人之記錄

相關紀錄係使用名稱、產品代碼或其他後設資料自動配對。配對結果並不構成已驗證的臨床、科學、企業或監管關係,請查閱連結的官方來源。

相關器械(代碼:GXH)

相關紀錄係使用名稱、產品代碼或其他後設資料自動配對。配對結果並不構成已驗證的臨床、科學、企業或監管關係,請查閱連結的官方來源。

官方來源

在 FDA 資料庫中查看 →

資料來源為 FDA Open API。如需最新且權威的資訊,請始終參閱官方記錄。

↑